A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Olga ProkopchukChris D HermannBenjamin SchoepsUlrich NitscheOleksii L ProkopchukPercy KnolleHelmut FriessMarc E MartignoniAchim KrügerPublished in: Journal of cachexia, sarcopenia and muscle (2021)
The TLC score, a result of straightforward determination of blood parameters, is an objective cachexia-associated clinical tool for precise survival prediction of gastrointestinal cancer patients.